“An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer -” (2013) Journal of Cancer Research Updates, 2(1), pp.  21–25. doi:10.6000/1929-2279.2013.02.01.4.